Acer Therapeutics Inc.
ACERDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069308
Acer Therapeutics Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 20, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $3.40M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Acer Therapeutics Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- 0 vs. Q2 2022
- Shares held
- 1.60M
- +42.9K (+2.8%) vs. Q2 2022
- Total value
- $2.22M
- +$262.0K (+13.4%) vs. Q2 2022
- New holders
- 2
- 9 more added
- Sold out
- 2
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACER on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $1.00K |
| Q3 2023 | 30 | $3.40M |
| Q2 2023 | 27 | $2.32M |
| Q1 2023 | 26 | $3.48M |
| Q4 2022 | 32 | $6.14M |
| Q3 2022 | 28 | $2.22M |
| Q2 2022 | 28 | $1.96M |
| Q1 2022 | 21 | $4.12M |
| Q4 2021 | 24 | $3.35M |
| Q3 2021 | 25 | $3.91M |
| Q2 2021 | 30 | $4.47M |
| Q1 2021 | 30 | $5.15M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Acer Therapeutics Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 696,538 | $968.0K | 0.09% | −44,472−6.0% | Reduced |
| Vanguard Group Inc | 278,634 | $387.0K | 0.00% | −1,785−0.6% | Reduced |
| BlackRock Inc. | 118,826 | $166.0K | 0.00% | −1,279−1.1% | Reduced |
| Geode Capital Management, LLC | 90,815 | $126.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 87,998 | $122.0K | 0.00% | −5,383−5.8% | Reduced |
| Renaissance Technologies LLC | 67,600 | $94.0K | 0.00% | −2,100−3.0% | Reduced |
| Citadel Advisors LLC | 52,125 | $72.0K | 0.00% | +29,551+130.9% | Added |
| Copperwynd Financial, LLC | 46,510 | $65.0K | 0.04% | +23,255+100.0% | Added |
| Northern Trust Corp | 22,551 | $31.0K | 0.00% | +3,145+16.2% | Added |
| State Street Corp | 20,225 | $28.0K | 0.00% | −3,240−13.8% | Reduced |
| Hunter Associates Investment Management LLC | 19,000 | $26.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 17,159 | $24.0K | 0.00% | +6,417+59.7% | Added |
| Susquehanna International Group, LLP | 16,193 | $23.0K | 0.00% | +16,193 | New |
| Simplex Trading, LLC | 12,877 | $17.0K | 0.00% | +10,186+378.5% | Added |
| Two Sigma Advisers, LP | 11,700 | $16.0K | 0.00% | −200−1.7% | Reduced |
| Bank of New York Mellon Corp | 11,075 | $15.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,626 | $15.0K | 0.00% | +10,593+32,100.0% | Added |
| Group One Trading, L.P. | 8,071 | $11.0K | 0.00% | +6,300+355.7% | Added |
| Tower Research Capital LLC (TRC) | 6,092 | $8.00K | 0.00% | +3,630+147.4% | Added |
| Morgan Stanley | 2,174 | $3.00K | 0.00% | −10.0% | Reduced |
| Larson Financial Group LLC | 922 | $1.00K | 0.00% | 00.0% | Unchanged |
| Burleson & Company, LLC | 365 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 179 | $249 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 48 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 70 | $0 | 0.00% | +2+2.9% | Added |
| JFS Wealth Advisors, LLC | 24 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 13 | $0 | 0.00% | +13 | New |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −381−100.0% | Sold out |